Combining enzalutamide with PARP inhibitors: Pharmaceutically induced BRCAness.

Oncotarget

Timothy C. Thompson: Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Published: November 2017

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706796PMC
http://dx.doi.org/10.18632/oncotarget.22074DOI Listing

Publication Analysis

Top Keywords

combining enzalutamide
4
enzalutamide parp
4
parp inhibitors
4
inhibitors pharmaceutically
4
pharmaceutically induced
4
induced brcaness
4
combining
1
parp
1
inhibitors
1
pharmaceutically
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!